文章名稱引用次數

• Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity24
• Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis23
• Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance13
• Refugia and anthelmintic resistance: Concepts and challenges12
• Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis10
• Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis10
• An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes10
• The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 201410
• Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis10
• Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs9